Effect of Intravenous Patient-controlled Analgesia (IV-PCA) With Fentanyl in Adults for Acute Postoperative Pain Control

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2012 by Yonsei University.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Yon Hee Shim, Yonsei University
ClinicalTrials.gov Identifier:
NCT01527890
First received: January 27, 2012
Last updated: February 2, 2012
Last verified: February 2012
  Purpose

In this retrospective study, the investigators examined incidence and risk factors of postoperative nausea and vomiting (PONV) in patients with fentanyl-based intravenous patient-controlled analgesia (IV-PCA).


Condition Intervention
Nausea
Vomiting
Drug: Fentanyl

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective

Resource links provided by NLM:


Further study details as provided by Yonsei University:

Estimated Enrollment: 2000
Study Start Date: February 2012
Estimated Study Completion Date: October 2012
Estimated Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)
Intervention Details:
    Drug: Fentanyl
    intravenous patient-controlled analgesia
  Eligibility

Ages Eligible for Study:   20 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients with Intravenous Fentanyl Patient-controlled Analgesia for postoperative pain control

Criteria

Inclusion Criteria:

  1. Adults between 20 to 60 years old
  2. Date from 1st, May 2011 to 31st, October 2011
  3. Patients with fentanyl based intravenous patient-controlled analgesia for postoperative pain control

Exclusion Criteria:

  1. Reoperation within 48 hours
  2. Patients who cannot express numerical rating scale for pain due to sedation
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01527890

Contacts
Contact: Yon Hee Shim, MD, PhD 82-2-2019-3547 ext 3547 tren125@yuhs.ac
Contact: Jong Bum Choi, MD 82-2-2019-3528 romeojb@naver.com

Locations
Korea, Republic of
Gangnam Severance Hospital Recruiting
Seoul, Korea, Republic of, 125-070
Contact: Yon Hee Shim, MD, PhD    82-2-2019-3547 ext 3547    tren125@yuhs.ac   
Sponsors and Collaborators
Yonsei University
  More Information

No publications provided

Responsible Party: Yon Hee Shim, Yonsei University College of Medicine, Yonsei University
ClinicalTrials.gov Identifier: NCT01527890     History of Changes
Other Study ID Numbers: 3-2011-0238
Study First Received: January 27, 2012
Last Updated: February 2, 2012
Health Authority: Korea: Food and Drug Administration

Keywords provided by Yonsei University:
intravenous patient-controlled analgesia
IV PCA

Additional relevant MeSH terms:
Nausea
Vomiting
Signs and Symptoms, Digestive
Signs and Symptoms
Fentanyl
Analgesics, Opioid
Narcotics
Central Nervous System Depressants
Physiological Effects of Drugs
Pharmacologic Actions
Analgesics
Sensory System Agents
Peripheral Nervous System Agents
Central Nervous System Agents
Therapeutic Uses
Adjuvants, Anesthesia
Anesthetics, Intravenous
Anesthetics, General
Anesthetics

ClinicalTrials.gov processed this record on August 21, 2014